Carl E Orringer (Carl Orringer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Low Density Lipoprotein

Extracorporeal Membrane Oxygenation

Respiratory Failure

Hepatitis B Virus

Top Venues

European heart journal

Current atherosclerosis reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias. European heart journal 45 (7) (2024)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias. European heart journal 44 (4) (2023)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias. European heart journal 44 (4) (2023)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias. European heart journal (2023)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias. European heart journal (2023)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Alberico Luigi Catapano
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias. European heart journal (2023)
Carl E Orringer
C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander? European heart journal (2023)
Sadberk Lale Tokgözoğlu, Carl E Orringer, Henry N Ginsberg, Alberico Luigi Catapano
The year in cardiovascular medicine 2021: dyslipidaemia. European heart journal 43 (8) (2022)
Carl E Orringer, Jelani K Grant, Lale Tokgozoglu
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms. Current atherosclerosis reports 24 (11) (2022)
Carl E Orringer
PCSK9 inhibition for acute arterial events: more than LDL lowering. European heart journal (2021)
Angelos D Karagiannis, Anurag Mehta, Devinder S Dhindsa, Salim S Virani, Carl E Orringer, Roger Scott Blumenthal, Neil J Stone, Laurence S Sperling
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol. European heart journal 42 (22) (2021)